Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 212 pages
Exam (elaborations)

NURS 6521 ADVANCED PHARMACOLOGY FINAL EXAM 300 MULTIPLE-CHOICE QUESTIONS WITH ANSWERS AND RATIONALES

Document preview thumbnail
Preview 4 out of 212 pages

Are you a Walden University nursing student preparing for the challenging NURS 6521 Advanced Pharmacology final exam? Do you need a targeted, high-yield study resource to master the complex mechanisms of drug action, interactions, and clinical applications across all body systems? This ultimate exam prep guide is your key to conquering the NURS 6521 final exam and achieving the top grade you deserve. This resource is more than just a collection of practice questions. It is a complete, immersive learning system featuring 300 meticulously crafted multiple-choice questions that mirror the exact format, style, and difficulty of the actual Walden NURS 6521 examinations. Every question is paired with a clear, concise, and detailed rationale, ensuring you don't just memorize answers but deeply understand the "why" behind each pharmacological principle, preparing you for critical thinking on exam day and in clinical practice. This comprehensive guide is systematically organized to mirror the official NURS 6521 curriculum, ensuring you are studying the most relevant material for your final exam. It covers all critical domains, including: Pharmacokinetics & Pharmacodynamics: Master the foundational principles of drug action. This section covers ADME (absorption, distribution, metabolism, elimination), half-life calculations, steady-state concepts, first-pass metabolism, protein binding, cytochrome P450 enzyme interactions (inducers and inhibitors), therapeutic index, volume of distribution, and clearance. Understand how renal and hepatic impairment affect drug dosing. Autonomic & Cardiovascular Pharmacology: Develop a deep understanding of drugs affecting the autonomic nervous system and the cardiovascular system. This section covers adrenergic and cholinergic agonists/antagonists, beta-blockers, calcium channel blockers, ACE inhibitors, ARBs, diuretics (loop, thiazide, potassium-sparing), digoxin, antiarrhythmics, anticoagulants (heparin, warfarin, DOACs), antiplatelet agents, and lipid-lowering therapies (statins, fibrates, ezetimibe). Antimicrobial Pharmacology: Conquer the complexities of infectious disease pharmacotherapy. Learn the mechanisms, spectra of activity, adverse effects, and drug interactions of penicillins, cephalosporins, vancomycin, fluoroquinolones, macrolides, aminoglycosides, tetracyclines, sulfonamides, metronidazole, and anti-TB drugs (INH, rifampin, ethambutol, pyrazinamide). Understand antibiotic resistance and superinfection risks. Neurological & Psychiatric Pharmacology: Master the pharmacology of central nervous system agents. This section covers antidepressants (SSRIs, SNRIs, MAOIs, TCAs), antipsychotics (typical and atypical), anxiolytics (benzodiazepines), anticonvulsants (phenytoin, carbamazepine, valproic acid, lamotrigine, levetiracetam), Parkinson's disease drugs (levodopa-carbidopa, dopamine agonists), and drugs for ADHD (stimulants, atomoxetine). Endocrine & Metabolic Pharmacology: Master the management of diabetes, thyroid disorders, and adrenal conditions. This section covers insulin preparations (rapid, short, intermediate, long-acting), oral hypoglycemics (metformin, sulfonylureas, SGLT2 inhibitors, GLP-1 agonists, TZDs), thyroid hormones (levothyroxine, liothyronine), antithyroid drugs (methimazole, PTU), and corticosteroids (prednisone, dexamethasone). Understand the management of osteoporosis (bisphosphonates, denosumab). Oncology & Immunopharmacology: Develop a comprehensive understanding of cancer chemotherapy and immunosuppressive agents. Learn about cytotoxic drugs (methotrexate, cyclophosphamide, doxorubicin, cisplatin), targeted therapies (imatinib, trastuzumab, rituximab, bevacizumab), and immunosuppressants used in transplantation (cyclosporine, tacrolimus, mycophenolate, sirolimus). Understand the management of chemotherapy side effects and tumor lysis syndrome. Special Populations & Patient Safety: Master the principles of pharmacotherapy in special populations, including pediatric, geriatric, and pregnant patients. Understand the importance of drug monitoring, adverse effect recognition, and the prevention of medication errors. Drug Interactions & Adverse Effects: Develop expertise in recognizing and managing clinically significant drug-drug interactions. This section covers interactions involving warfarin, digoxin, lithium, theophylline, and drugs metabolized by CYP450 enzymes. Understand the risks of serotonin syndrome, QT prolongation, and nephrotoxicity. Why this guide is your #1 strategy for NURS 6521 success at Walden: Exam-Focused Practice: The 300 questions are designed to simulate the actual Walden NURS 6521 final exam environment, significantly reducing test anxiety and building your confidence for the real thing. Learn Through Detailed Rationales: Transform passive reading into active learning. Each rationale provides the "why" behind the answer, deepening your comprehension of complex pharmacological mechanisms and their clinical applications. Stay Current with 2026 Standards: This guide reflects the latest advancements in pharmacology and nursing education, ensuring you are studying the most up-to-date material. Gain a Competitive Edge: By working through hundreds of realistic questions, you'll gain a significant advantage over fellow students, ensuring you are fully prepared for all types of questions on the NURS 6521 final exam.

Content preview

NURS 6521 ADVANCED PHARMACOLOGY FINAL
EXAM 300 MULTIPLE-CHOICE QUESTIONS WITH
ANSWERS AND RATIONALES




SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS (Questions 1-40)



Question 1

A patient asks why a higher dose of a medication is needed orally compared to IV.
What is the nurse's best response?



A. "Oral medications are absorbed faster, so they are broken down quicker."

B. "The liver metabolizes a portion of the oral drug before it reaches the
bloodstream."

C. "Oral medications bind to protein in the stomach, making them inactive."

D. "The kidneys filter out oral medications more efficiently than IV medications."



Correct Answer: B



Rationale: This describes the first-pass effect. Orally administered drugs are
absorbed from the GI tract and carried via the hepatic portal system to the liver,

,where significant metabolism may occur before reaching systemic circulation.
This reduces bioavailability and requires higher oral doses compared to IV
administration .



---



Question 2

A drug has a half-life of 12 hours. How long will it take to reach steady state?



A. 12 hours

B. 24 hours

C. 60 hours

D. 72 hours



Correct Answer: C



Rationale: Steady state is typically achieved after approximately 4-5 half-lives.
Therefore, 12 hours × 5 = 60 hours. At this point, drug accumulation and
elimination reach equilibrium .



---



Question 3

,A nurse is reviewing lab results and notes a drug has a narrow therapeutic index
(NTI). What is the primary implication of this characteristic?



A. The drug has a wide margin of safety.

B. The drug requires routine monitoring of serum levels.

C. The drug does not require dosage adjustments.

D. The drug is safe for over-the-counter use.



Correct Answer: B



Rationale: A narrow therapeutic index means the difference between the
minimum effective concentration and the toxic concentration is small. Small
changes in dose or metabolism can lead to toxicity, necessitating close monitoring
(e.g., Warfarin, Digoxin, Phenytoin) .



---



Question 4

A patient is taking Drug A and a newly prescribed Drug B. The nurse notes that
Drug B displaces Drug A from plasma albumin. What is the expected result?



A. Decreased effect of Drug A

B. Increased free fraction of Drug A

, C. Increased excretion of Drug A

D. Decreased absorption of Drug B



Correct Answer: B



Rationale: Displacement from protein binding sites increases the amount of free
(unbound) drug in circulation. Only free drug is pharmacologically active,
potentially increasing the effect and risk of toxicity of Drug A .



---



Question 5

A patient with hepatic cirrhosis is prescribed a drug metabolized by the liver.
What adjustment is needed?



A. Increase the dose

B. Decrease the dose

C. No change needed

D. Change to IV route



Correct Answer: B

Document information

Uploaded on
August 20, 2026
Number of pages
212
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$20.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
0
Followers
0
Items
31
Last sold
-


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions